About This Reference Desk

What TSMMA Peptides is

TSMMA Peptides is an independent editorial reference desk covering the published research on two peptides studied for metabolic regulation and weight management: MOTS-c and tesamorelin, with MOTS-c as the lead. The site exists to put two very different compounds — one with no human efficacy data, one with an FDA approval — in a single, honest frame so that a reader can understand what distinguishes a preclinical signal from a clinical proof, and what the limits of even a genuine regulatory approval are.

The organizing question is a metabolic one: how do these two peptides claim to affect the way the body handles energy, fat, and glucose, and what does the peer-reviewed literature actually say? Each compound has its own page; a comparison page places them side by side; and a single shared references list aggregates every cited source across the desk.

How it is compiled

Three principles govern what appears here.

First, everything is anchored to the peer-reviewed literature. Every research claim is tied to a numbered citation — PubMed-indexed journal articles and reviews, systematic reviews and meta-analyses, regulatory monographs — collected on the references page. Where a finding comes from a review rather than a primary study, the review is cited as such.

Second, the evidence is reported at its true strength and scope. Doses are described as studied — for example, tesamorelin 2 mg/day in HIV-positive adults — never scaled or extrapolated to other populations. Where a regulatory approval exists, its exact indication is stated and its limits are described with equal care. Where evidence is preclinical or observational, the page says so plainly rather than letting the framing imply clinical translation that does not exist.

Third, the two pages are cross-referenced. Because both compounds touch energy metabolism via different mechanisms — mitochondrial AMPK activation on one side, GH/IGF-1 lipolysis on the other — the pages link to each other and to the comparison, so a reader can follow the contrast across the desk.

What it is not

TSMMA Peptides is not a store, not a clinic, and not a source of medical advice. It does not sell, supply, source, or broker any peptide or research chemical, and it has no affiliate or referral relationship with any vendor. It does not employ clinicians, diagnose conditions, or prescribe anything. It does not recommend a dose, schedule, or route of administration for any person, and it never frames a dose from an animal study or a clinical trial in one defined population as something a general reader should replicate.

The peptides discussed here occupy different regulatory categories: one holds a narrow prescription approval, one has no approval at all. Neither is an over-the-counter product, and neither has an established safety profile for general self-administration. Readers with questions about any condition touched by the research on this desk should consult a licensed clinician in their own jurisdiction. The value this site offers is an accurate, candid map of the published literature — nothing more.